Clinical trial

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00206635

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2005-01-01

PhaseN/A

Study timeline

Study start (unknown)2005-01-01Date precision: month

Registry last updated2012-11-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Interferon beta-1b (Betaseron, BAY86-5046)DRUG

Sponsors & collaborators

Bayerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00206635 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.